Background illustration for clinical trials search

Paid Clinical Trials Everett

Discover 1,443 paid clinical trials in Everett, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

for
Non-Small Cell Lung Cancer
Location: Tacoma WA, Wenatchee WA, Vancouver, Vancouver WA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06357533

Phase 3, Recruiting

Resistance to HIV Infection

for
HIV Infections
Location: Seattle WA
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 60

Code: NCT00069485

Recruiting

Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

for
HIV Infections
Location: Seattle WA, San Francisco CA, Kansas City MO, Dallas TX,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07682961

Phase 3, Recruiting

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

for
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements,
Location: Seattle WA, Hood River OR, Portland OR, Oregon City OR,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06649812

Phase 2, Recruiting

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

for
Prostate Cancer
Location: Seattle WA, Tacoma WA, Palo Alto CA, Santa Barbara CA,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06855277

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Prevail Global Study

for
Coronary Artery Disease
Location: Seattle WA, Vancouver, Portland OR, Missoula MT,
Sponsor: Medtronic Vascular

Sex: All

Age: 18+

Code: NCT06535854

Recruiting

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

for
Primary Progressive Multiple Sclerosis,
Location: Seattle WA, La Jolla CA, Rochester MN, Kansas City KS,
Sponsor: Tr1X, Inc.

Sex: All

Age: 18 - 65

Code: NCT07477639

Phase 1, Phase 2, Recruiting

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

for
Astrocytoma, IDH-Mutant, Grade 3
Location: Seattle WA, Portland OR, Roseville CA, Sacramento CA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 12+

Code: NCT07215910

Phase 3, Recruiting

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab

for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Seattle WA, Portland OR, Boise ID, Sacramento CA,
Sponsor: PPD Development, LP

Sex: All

Age: 18+

Code: NCT06701682

Phase 2, Recruiting

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

for
Multiple Myeloma
Location: Seattle WA, La Jolla CA, Rochester MN, Dallas TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05137054

Phase 1, Recruiting

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

for
Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Location: Tacoma WA, Portland OR, Eugene OR, Boise ID, Calgary,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06806033

Phase 2, Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for
Triple Negative Breast Cancer
Location: Puyallup WA, Lacey WA, Portland OR, Corvallis OR,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT05633654

Phase 3, Recruiting

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)

for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Seattle WA, Portland OR, Boise ID, Sacramento CA,
Sponsor: PPD Development, LP

Sex: All

Age: 18+

Code: NCT06703073

Phase 2, Recruiting

Unobtrusive Sensing of Medication Intake ("USE-MI")

for
Medication Adherence
Location: Seattle WA
Sponsor: Swedish Medical Center

Sex: All

Age: 18+

Code: NCT03571022

Recruiting

Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer

for
Ovarian Neoplasms, Ovarian Epithelial Carcinoma,
Location: Seattle WA, Little Rock AR, Baltimore MD, Annapolis MD,
Sponsor: Massachusetts General Hospital

Sex: Female

Age: 30+

Code: NCT04794322

Recruiting

Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus

for
Esophageal Stricture
Location: Seattle WA, Portland OR, Salt Lake City UT,
Sponsor: GIE Medical

Sex: All

Age: 22+

Code: NCT05561114

Phase 3, Recruiting

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

for
Chronic Obstructive Pulmonary Disease, Obstructive Sleep Apnea,
Location: Seattle WA, Spokane WA, Boise ID, Minneapolis MN,
Sponsor: Seattle Institute for Biomedical and Clinical Research

Sex: All

Age: 18+

Code: NCT06390345

Recruiting

Cephea Early Feasibility Study

for
Mitral Regurgitation
Location: Seattle WA, Sacramento CA, Thousand Oaks CA,
Sponsor: Abbott Medical Devices

Sex: All

Age: 18+

Code: NCT05061004

Recruiting

Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic

for
Thoracoabdominal Aortic Aneurysm, Without Rupture
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT01874197

Recruiting

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

for
Acne
Location: Seattle WA, Missoula MT, Edmonton, Santa Rosa CA,
Sponsor: Sanofi Pasteur, a Sanofi Company

Sex: All

Age: 18 - 45

Code: NCT06316297

Phase 1, Phase 2, Recruiting